Use the Capella University Library and the Internet to prepare for this assessment. Include the following activities as part of your preparation:

  • In addition to reading the suggested articles listed in the Resources, perform a Web search for “oral testimony tips” to compare and contrast suggestions from more than one type of advocacy group.
  • Visit the Archives and view three or four recorded oral testimonies.

POWERPOINT PRESENTATION

Condense your written testimony into a 5-minute-long recorded oral presentation. Create a 3–5-slide PowerPoint to present a structure to guide your recording. Follow this structure for your presentation:
  • Introductory remarks: Includes acknowledgement of committee chair and members, your credentials as the person preparing the testimony, and the organization you are representing.
  • Background: Brief statement regarding justification for the proposed policy.
  • Specific aspect of the issue: Summarize key points of the desired outcomes from the proposed policy with cited references. Provide a summary of current interventions for your specific issue and why additional action is needed.
  • Recommendations: Provide specific recommendations for the committee and those being implemented by the special interest group.
  • Concluding statement: One or two sentences summarizing why the committee should consider your proposed policy.
  • Closing: Thank the committee for the opportunity and note your availability for additional discussion or questions.

ADDITIONAL REQUIREMENTS for MHAFP5032 Policy and Pharmaceutical Regulation Presentation

  • Number of slides: Approximately 3–5 (length should correspond with, and not exceed, content that would amount to five minutes of oral testimony).
  • Slide design: Use the notes section for your speaker notes. The slide design must meet the expectations of a professional presentation (bullet points, large font size, plenty of white space).
  • Oral communication: Use persuasive oral presentation techniques such as staying on topic, integrating your slides with your presentation, and staying within the time allotment.
This is what needs to be on the PowerPoint Presentation: MHAFP5032 Policy and Pharmaceutical Regulation Presentation Introduction A special acknowledgement the committee chairperson who happens to be the president and founder of Patients for Affordable Drugs, I also acknowledge the members of the committee who are boards members of the organization. This testimony has been prepared by the director of Patients for Affordable Drugs. MHAFP5032 Policy and Pharmaceutical Regulation Presentation Background Processes followed by pharmaceutical companies in the US are not made known to the public, and the patients have been at a disadvantage owing to the skyrocketed prices. The current pricing policy I place makes an allowance for the manufactures as there are no strict regulations that dictate the way pricing decisions are made. In addition, brand-named products are facing no significant competition in the market, owing to the stringent approval policies of generic drugs. As of now, the FDA has in place a rigorous metric array which gauges the standards and market-worthiness of any generic drugs. Moreover, the approval process takes time that is if a generic drug will be accepted by the FDA. All these factors bars competition in the market hence the continuous increase of drug prices in the country. The desired health policy change is centered on loosening the strictness of the FDA in terms of the generic drugs approval process. Realizing this change will mean that new generic drugs will be easily approved, though complying with all required standards. Competition in the market will be stirred as patients will have alternatives to highly priced brand-name drugs. In response, pharmaceutical companies will be forced to standardize their drugs prices to remain competitive in the market.